Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study)
NCT04018482 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2020-03-10
Summary
To compare the efficacy and comfort of two FDA approved pre-injection antiseptics when used for intravitreal injections.
Conditions
- Age-related Macular Degeneration
- Diabetic Retinopathy
- Diabetic Macular Edema
Interventions
- OTHER
-
Povidone Iodine
FDA-approved disinfectant for intravitreal injections
- OTHER
-
Hypochlorous Acid
FDA-approved disinfectant for intravitreal injections
Sponsors & Collaborators
-
California Retina Consultants
lead OTHER
Principal Investigators
-
Robert Avery, MD · California Retina Consultants
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-16
- Primary Completion
- 2019-08-14
- Completion
- 2019-08-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
NCT00877032 ·Status: COMPLETED ·Phase: PHASE1
-
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
NCT03203447 ·Status: TERMINATED ·Phase: PHASE3
-
Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium
NCT01573572 ·Status: COMPLETED ·Phase: PHASE4
-
Resistance to Antibiotics in Patients Receiving Eye Injections
NCT02126423 ·Status: COMPLETED
-
Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration
NCT01245387 ·Status: COMPLETED
-
Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
NCT02457026 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
NCT01027650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)
NCT00109499 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
NCT05698329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy
NCT01487070 ·Status: COMPLETED ·Phase: PHASE1
-
Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)
NCT00087763 ·Status: COMPLETED ·Phase: PHASE2
-
Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degeneration
NCT06174181 ·Status: COMPLETED ·Phase: NA
-
Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
NCT00134667 ·Status: TERMINATED ·Phase: PHASE4
-
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
NCT00090532 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
NCT01003691 ·Status: COMPLETED ·Phase: PHASE1
-
Supplemental Adjuvants for Intracellular Nutrition and Treatment
NCT00893724 ·Status: UNKNOWN ·Phase: NA
-
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration
NCT00460408 ·Status: COMPLETED
-
Ocular Safety and Usability Study for FYB201 PFS
NCT06708624 ·Status: COMPLETED ·Phase: PHASE4
-
A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema
NCT01487044 ·Status: AVAILABLE
-
Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD
NCT02859766 ·Status: COMPLETED ·Phase: PHASE1
-
A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration
NCT04640272 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD
NCT00041483 ·Status: COMPLETED ·Phase: PHASE3
-
Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)
NCT01186432 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular Degeneration
NCT02591914 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
NCT01589718 ·Status: WITHDRAWN ·Phase: PHASE3